Abstract
Peptides in the 3-kDa ultrafiltrate of fermented whey protein isolate (WPI) medium could be responsible for the antivirulence activity of Lactobacillus helveticus LH-2 and Lactobacillus acidophilus La-5 against Salmonella Typhimurium. Non-fermented and fermented media containing 5.6% WPI were fractionated at a 3 kDa cut-off and the filtrate was analyzed by mass spectrometry. The non-fermented WPI medium contained 109 milk derived peptides, which originated from β-casein (52), αs1-casein (22), αs2-casein (10), κ-casein (8), and β-lactoglobulin (17). Most of these peptides were not found in the fermented media, except for 14 peptides from β-casein and one peptide from αs2-casein. Database searches confirmed that 39 out of the 109 peptides had established physiological functions, including angiotensin-converting-enzyme (ACE) inhibitory, antioxidant, antimicrobial, or immunomodulating activity. A total of 75 peptides were found in the LH-2 cell free spent medium (CFSM): 54 from β-casein, 14 from k-casein, 4 from β-lactoglobulin and 3 from αs2-casein. From these peptides, 19 have previously been associated with several categories of bioactivity. For La-5 CFSM, a total of 15 peptides were sequenced: 8 from β-casein, 5 from αs1-casein, 2 from β-lactoglobulin. Only 5 of these have previously been reported as having bioactivity. Many of the peptides remaining in the fermented medium would contain low-affinity residues for oligopeptide binding proteins and higher resistance to peptidase hydrolysis. These properties of the sequenced peptides could explain their accumulation after fermentation despite the active proteolytic enzymes of LH-2 and La-5 strains. Down-regulated expression of hilA and ssrB genes in S. Typhimurium was observed in the presence of La-5 and LH-2 CFSM. Downregulation was not observed for the Salmonella oppA mutant strain exposed to the same CFSM used to treat the S. Typhimurium DT104 wild-type strain. This result suggests the importance of peptide transport by S. Typhimurium for down regulation of virulence genes in Salmonella.
Keywords: bioactive peptides, probiotic, whey, Salmonella, virulence, gene expression
Introduction
Salmonella enterica subsp. enterica serovar Typhimurium is considered a major foodborne pathogen with public health and economic concerns. This foodborne pathogen has developed resistance against a broad range of antibiotics (1). Alternative approaches to control this pathogen depending on the inhibition of virulence gene expression and stimulation of the host immune system have been suggested. These approaches cause less stress to bacterial cells to avoid the development of resistant clone (2). A Type III Secretion System (TTSS) is used by S. Typhimurium to inject and translocate effector proteins into host cells for adherence, attachment and invasion (3). Salmonella pathogenicity island I (SPI1) controls the production and activity of the Type III secretion system which enables the membrane ruffling process, in which the epithelial cell cytoskeleton is rearranged to engulf the Salmonella into cytoplasmic vacuoles (4). The gene hilA directly controls and activates all the genes of SPI1 for invasion (5). The gene ssrB is the main regulator of SPI2, which is responsible for systemic infection and replication of S. Typhimurium inside macrophages and epithelial cells (6). Down regulation of these virulence genes would be an alternative way to reduce the severity of Salmonella infection.
Milk proteins are a major source of bioactive peptides (7). Milk derived peptides may have effects on the digestive, immune, cardiovascular and nervous systems (8). Previous studies have suggested that bioactive metabolites produced by L. helveticus LH-2 and L. acidophilus La-5 could down-regulate virulence gene expression in both Salmonella and E. coli O157:H7 after growth in chemically defined media and milk (9–12).
Bioactive peptide production in lactic acid bacteria (LAB) is the result of the balance between proteolytic activity and peptide consumption (13). The proteolytic system of LAB consists of proteinases and peptidases which initially cleave milk proteins to oligopeptides, specific transport proteins which transport smaller peptides and amino acids across the cytoplasmic membrane and intracellular peptidases, which further degrade these peptides to small peptides and amino acids (14). The considerable amino acid auxotrophy of L. helveticus and L. acidophilus is consistent with the presence of many peptidases/proteases and related transport systems for amino acids and peptides (15).
The oligopeptide-binding protein (OppA) is one of the most abundant periplasmic proteins in S. Typhimurium. oppA gene expression in S. Typhimurium is modulated by nitrogen compounds and regulates the expression of other genes such as Lrp (leucine-responsive regulatory protein) or CodY (16). Mutation in OppA in S. Typhimurium leads to losing the ability to transport muropeptides and detect the nutritional or signaling peptides (17).
In this study, the proteolytic and peptidolytic activities of LH-2 and La-5 strains in Whey Protein Isolate (WPI) are explored through genome sequencing and biochemical assays on substrates. Peptide profile analysis by mass spectrometry was conducted to understand the potential factors that lead to accumulation of antivirulence peptides in the growth media. Furthermore, the correlation between oppA gene expression and virulence gene expression in Salmonella in the presence of antivirulence peptides was investigated using a S. Typhimurium oppA mutant strain.
Materials and Methods
Bacterial Strains and Growth Conditions
All bacterial strains used in this study were obtained from the Canadian Research Institute for Food Safety (CRIFS) except for the Salmonella Typhimurium oppA mutant, which was provided by Prof. Eric Brown, McMaster University. Lactobacillus helveticus LH-2 and Lactobacillus acidophilus La-5 probiotic strains were grown under anaerobic conditions at 37°C for 48 h on De Man, Rogosa, Sharpe broth (MRS; Thermo Scientific™ Oxoid™ Ottawa, ON, Canada). Salmonella Typhimurium hilA::lux and Salmonella Typhimurium ssrB::lux were grown on Luria-Bertani broth (LB; Life Technologies, Burlington, ON, Canada) supplemented with 50 μg/ml of ampicillin (Amp). Both constructs were grown aerobically overnight on a shaking incubator at 37°C. S. Typhimurium DT104 and S. Typhimurium oppA mutant strains were grown under the same condition as S. Typhimurium constructs, but without Amp. Solid media preparation for all strains were carried out under the same conditions but with addition of 15 g/l of agar and incubated under the same conditions.
Preparation of L. helveticus LH-2 and L. acidophilus La-5 Cell Free Spent Medium (CFSM)
Whey Protein Isolate (WPI) (NZWPI 895, Caldic, Fonterra, USA) was dissolved at 5.6% (v/v) in sterile sugar solution. Glucose or sucrose (Fisher Scientific, Ottawa, ON, Canada) at 0.5% (v/v) were added for L. helveticus LH-2 and L. acidophilus La-5, respectively. The media were filter sterilized through 0.45 μm pore-size filters (Corning, NY 14831, Germany). An overnight culture of each strain in MRS broth was washed and inoculated at 5% (v/v) into WPI based media and incubated anaerobically at 37°C for 48 h. Following growth, bacterial cells were removed by centrifugation at 15,000 × g for 30 min at 4°C. The supernatant was filtered through a 0.20 μm pore-size filter (Corning) to obtain sterile CFSM which was subsequently freeze-dried (VirTis, Genesis, USA) for 72 h and stored at −80°C.
Effect of CFSM on Gene Expression in S. typhimurium Reporter Constructs
For initial screening of the antivirulence effects of CFSM, bioluminescent reporter strains S. Typhimurium hilA::lux and ssrB::lux (18) were used. Briefly, the luxCDABE operon from Xenorhabdus luminescens was isolated and cloned with an Amp resistance gene into a plasmid (pSB377), which was further fused with the hilA and ssrB promoter regions, separately. The expression of the lux genes is controlled by these promoter regions, so that light is emitted when the gene is expressed. Each overnight culture of the constructs was diluted 1:100 with fresh LB broth with and without supplementation of 10% (v/v) of neutralized (pH 7) CFSM from L. helveticus LH-2 and L. acidophilus La-5, which had been reconstituted in sterile deionized water at 10-fold concentration compared to the initial medium. The samples were incubated aerobically at 37°C with shaking for 3 h. Luminescence was measured with the FB 12 luminometer (Berthold Detection Systems, Pforzheim, Germany). The results are presented as Relative Light Units (RLU)/OD600 nm.
Effect of CFSM and Mixture of Synthetic Peptides on Transcription of Virulence Genes of S. typhimurium by RT-qPCR
RNA Extraction
RNA was extracted from S. Typhimurium DT104 and S. Typhimurium oppA mutant following 3 h growth in fresh LB broth with and without 10% neutralized (pH 7) CFSM with shaking at 37°C, 2-ml samples were centrifugated at 5,000 × g for 4 min at RT. The supernatant was discarded and cells were mixed with 1 ml of RNA Protect reagent (Qiagen Inc., Mississauga, ON, Canada) and incubated for 5 min at RT. Cells were collected again by centrifugation at 5,000 × g for 10 min at RT. Cell pellets were suspended in 200 μl of Tris-EDTA buffer, pH 8.0 (Fisher Scientific, Ottawa, ON, Canada), 60 μl of 20 mg/ml lysozyme (Fisher Scientific) and 20 μl of proteinase K (Qiagen). The suspensions were incubated at 37°C for 1 h with shaking at 450 rpm. RNeasy Plus Mini Kit (Qiagen) was used to extract RNA from all samples following the manufacturer's instructions. DNA was eliminated by using RNase-Free DNase Set (Qiagen). In brief, 40 μl of total RNA was incubated for 10 min at RT with 2.5 μl DNase I stock solution, 10 μl RDD buffer in a total volume of 100 μl. RNA purification and concentration were performed with RNeasy MinElute Cleanup kit (Qiagen) and solubilized in 30 μl molecular-grade water. The quantity of quality RNA was determined by measuring the absorbance at 260 and 280 nm using a NanoDrop 1000 spectrophotometer (Thermoscientific, Wilmington, DE 19810, USA). RNA integrity was verified by gel electrophoresis.
The same procedures were used for a mixture of the following synthetic peptides (GLDIQKVAGT, ELNVPGEIVES, DVENLHLPLPL, GVSKVKEAMAPKH, SSSEESITRIN) (Synpeptide) at a concentration of 0.2 mg/ml for each peptide.
Reverse Transcription
The purified RNA was used for reverse transcription by using high-capacity cDNA reverse transcription kit (Applied Biosystems, Burlington, ON, Canada). RNA (1 μg) was mixed with 2 μl of 10× RT buffer, 2 μl of 10× random hexamer primers, 0.8 μl of 25× dNTP (100 mM), 1 μl of Multiscribe reverse transcriptase (50 U/ml) in a total volume of 20 μl. A no reverse transcription control was included to confirm the absence of contaminating DNA. The synthesis of cDNA was conducted using a Mastercycler Gradient Thermocycler (Eppendorf, Mississauga, ON, Canada) under the following settings: 25°C for 10 min, 37°C for 120 min, 85°C for 5 min and a holding step at 4°C. The cDNA was stored at −20°C until use.
RT-qPCR
A ViiATM 7 Real-Time PCR System (Applied Biosystems, Burlington, ON, Canada) and PowerUp™ SYBR™ Green Master Mix (Applied Biosystems) were used for RT-qPCR. The primers (Table 1) were synthesized by Eurofins Genomics (Huntsville, USA). The primer efficiency was calculated as described before (23) with the formula: E = 10 (−1/slope). The PCR was performed in a total volume of 20 μl; 10 μl of PowerUp™ SYBR™ Green Master Mix, 1.6 μl of forward primer (5 μM), 1.6 μl of reverse primer (5 μM), 5 μl of 1/10 diluted cDNA and 1.8 μl of molecular-grade water with the final primer concentration of 400 nM for all the genes except 16S (ribosomal RNA gene) and rpoD (sigma factor). For these two genes, a final primer concentration of 200 nM was used with reaction mixture, 10 μl of SYBR® Select Master Mix, 0.8 μl of forward primer (5 μM), 0.8 μl of reverse primer (5 μM), 5 μl of 1/10 diluted cDNA and 3.4 μl of molecular-grade water. Each PCR was performed in triplicate in the 96 well plates (MicroAmp™ Optical 96-Well Reaction Plate with Barcode, Fisher Scientific, Canada). PCR conditions were as follows: UDG activation at 50°C for 2 min and Dual-Lock™ DNA polymerase activation at 95°C for 2 min, followed by 40 repeated cycles of denaturation, annealing and amplification, at 95°C for 15 s, 54°C for 30 s and 72°C for 45 s. Subsequently, a default dissociation curve (95°C for 15 s, 60°C for 1 min and 95°C for 15 s) was performed in the instrument and specific amplicon was verified by a single melting-temperature peak. The transcript levels were normalized to the geometric average of expression for all housekeeping genes for each sample (24). The relative changes in gene expression were calculated by using the formula: dCT = CT (target)-CT (Normalizer), then ddCT is calculated by subtracting the dCT of the untreated sample from the treated one: ddCT = dCT (treated)- dCT (untreated). The relative gene expression is calculated as, 2−ddCT. Finally, a fold change was calculated as −1/2−ddCt (25).
Table 1.
Gene | Function | Primer sequences | References |
---|---|---|---|
hilA | Transcriptional regulator of SPI-1 | F: 5′-TGTCGGAAGATAAAGAGCAT-3′R: 5′-AAGGAAGTATCGCCAATGTA-3′ | (19) |
ssrB2 | Transcriptional regulator of SPI-2 | F: 5′-TGGTTTACACAGCATACCAA-3′R: 5′-GGTCAATGTAACGCTTGTTT-3′ | (19) |
16S | 16S rRNA gene, used as housekeeping gene | F: 5′-CAAGTCATCATGGCCCTTAC-3′R: 5′-CGGACTACGACGCACTTTAT-3′ | (20) |
ropD | Sigma factor, used as housekeeping gene | F: 5′-GTGAAATGGGCACTGTTGAACTG-3′R: 5′-TTCCAGCAGATAGGTAATGGCTTC-3′ | (21) |
gmk | Guanylate kinase, used as housekeeping gene | F: 5′-TTGGCAGGGAGGCGTTT-3′R: 5′-GCGCGAAGTGCCGTAGTA AT-3′ | (22) |
Genome Sequencing of L. helveticus LH-2 and L. acidophilus LA-5
Genomic DNA was extracted from L. helveticus LH-2 and L. acidophilus La-5 by using the UltraClean Microbial DNA Isolation Kit (Mo-Bio Laboratories, Inc., Canada) according to the manufacturer's instructions. DNA was eluted in 10 mM Tris-HCl (pH 8.0). The concentration and the purity of the purified DNA was measured at 260 and 280 nm using a Nanodrop 1000 spectrophotometer. The integrity of the DNA was verified by agarose (1%) gel electrophoresis. Extracted DNA samples were stored at −20°C. Library preparation and sequencing were performed at the Plateforme d'Analyses Génomiques of the Institut de Biologie Intégrative et des Systèmes (IBIS, Université Laval Quebec, Canada). In short, the libraries were prepared using 500 ng of mechanically fragmented DNA by a Covaris M220 (Covaris) using the NEBNext Ultra II kit (New England Biolabs). TruSeq HT adapters (Illumina) were ligated instead of NEBNext adaptors. The libraries were checked for quality using Bioanalyzer and quantified with Picogreen. The libraries were sequenced on a fraction of a MiSeq run (v3 600 cycles, Illumina) following the manufacturer's instructions. De novo assembly of the reads was performed using CLC Bio Genomic Workbench version 10.1 (Qiagen Inc., Mississauga, ON, Canada) at the Genomics Facility of the Advanced Analysis Centre, University of Guelph. Both the assembled reads and the de novo assembled contigs were BLAST searched (https://blast.ncbi.nlm.nih.gov/Blast.cgi). Comparative genomic analysis of the proteolytic system was conducted using other related strains L. helveticus CNRZ 32 (abbreviation LAC LHE, accession number CP002081) for L. helveticus LH-2 and L. acidophilus NCFM (abbreviation LAC, accession number CP000033) for L. acidophilus La-5 using the NCBI microbial genome database and Blast alignment tools.
Measurement of the Cell Envelope Proteinase (CEP) Activities
L. helveticus LH-2 and L. acidophilus La-5 were grown anaerobically in WPI—sugar based medium supplemented with 10 mM CaCl2.2H2O at 37°C for 24 h. The cells were harvested by centrifugation at 15,000 × g for 10 min at 4°C and washed twice with 10 mM CaCl2-saline solution. The supernatant designated as extracellular extract (EE) was used for the measurement of cell lysis rate while the cells were re-suspended in Tris buffer (50 mM, pH 7.8) to an optical density at 600 nm (OD600) of approximately 10 and were used for CEP and aminopeptidase enzyme assays.
The CEP activity assay of intact cells was performed using the chromogenic substrate N-succinyl-Ala-Ala-Pro-Phe-p-nitroanilide (Sigma, Markham, ON, Canada) as described previously (26). The reaction mixture was consisted of 200 μl resuspended cells, 287.5 μl phosphate buffer (0.2 M, pH 7.0), 225 μl 5 M NaCl and 37.5 μl N-succinyl-Ala-Ala-Pro-Phe-p-nitroanilide (20 mM). The reaction components were mixed gently and incubated at different temperatures (35, 40, 45, 50, and 55°C) for 30 min to determine the effect of temperature on the proteinase activity. The reactions were stopped by adding 175 μl of 80% (v/v) acetic acid followed by centrifugation at 13,000 × g for 5 min. The release of p-nitroanilide (pNA) was measured at 410 nm using Beckman DU 500-Spectrophotometer. The enzyme activity was calculated using a molar absorption coefficient (ε) of 8,800 mol−1cm−1. One unit of protease activity was defined as 1 nmol of p-nitroanilide released per minute. The specific protease activity was calculated as one unit of protease from 1 mg of cell protein. The protein content was estimated using the method of Bradford (27). Bovine serum albumin (Thermoscientific, Rockford, USA) was used as a standard to measure the protein content.
Aminopeptidase Activities
Suspensions of harvested cells with OD600 of approximately 10 were used for preparation of intracellular extracts (IE) according to Pescuma et al. (28), cells were disrupted by using Microbead tubes (Mo-Bio Laboratories, Inc., Canada) in a microbead tube vortex for 6 min at maximum speed with 1 min interruption on ice after each minute. Beads, cell debris and unbroken cells were removed by centrifugation (10,000 × g at 4°C for 5 min) and the supernatant fluid was designated as the intracellular enzymatic extract (IE) which was maintained on ice and immediately used for enzymatic assays. Intracellular aminopeptidase activity was assayed with the chromogenic substrate Lys-ρNa (Sigma) as previously described (29) by incubation of 100 μl of IE with 400 μl of Tris-HCl buffer (50 mM, pH 7.0) and 50 μl Lys-ρNa (10 mM) at five temperatures (35, 40, 45, 50, and 55°C) for 20 min to determine the effect of temperature on the aminopeptidase activity. The reaction was stopped by addition of 1 mL of 30% acetic acid. The concentration of ρ-nitroanilide released was quantified at 410 nm. Enzyme activities were calculated by using a molar absorbance coefficient of 9,024 mol−1cm−1 under the assay conditions. One unit of enzyme activity was defined as the amount of enzyme required to release 1 nmol of ρ-nitroanilide per min under the assay conditions. The specific peptidase activity was calculated as one unit of peptidase from 1 mg of cell protein. Aminopeptidase activity was measured in EE by the same procedures to detect rate of cell lysis.
Identification of Peptides Through Liquid Chromatography–Mass Spectrometry Analysis (LC–MS)
Filtered CFSM was fractionated at three successive cut-off protein concentrator sizes 100, 50, and 3 kDa, respectively, using GE Healthcare Vivaspin™ 20 protein concentrator (Fisher Scientific). The filtrate was freeze dried for 72 h. A control sample of filter sterilized WPI CFSM was included. The freeze-dried filtrate of 30 ml CFSM was reconstituted in 300 μl Milli-Q water and peptides were identified on an Agilent 1200 HPLC liquid chromatograph interfaced with an Agilent UHD 6530 Q-Tof mass spectrometer at the Mass Spectrometry Facility of the Advanced Analysis Centre, University of Guelph (30). Briefly, a C18 column (Agilent Advance Bio Peptide Map, 100 × 2.1 mm 2.7 μm) was used for chromatographic separation with the following solvents, water with 0.1% formic acid for A and acetonitrile with 0.1% formic acid for B. The mobile phase gradient was 2% B increasing to 45% B in 40 min and then to 55% B in 10 more minutes followed by column wash at 95% B and 10-min re-equilibration with a flow rate 0.2 mL/min.
The mass spectrometer electrospray capillary voltage was maintained at 4.0 kV and the drying gas temperature at 350°C with a flow rate of 13 L/min. Nebulizer pressure was 40 psi and the fragmentor was set to 150. Nitrogen was used as both nebulizing and drying gas, and collision-induced gas. The mass-to-charge ratio was scanned across the m/z range of 300–2,000 m/z in 4 GHz extended dynamic range positive-ion auto MS/MS mode. Three precursor ions per cycle were selected for fragmentation. The sample injection volume was 20 μl. Raw data files were loaded directly into PEAKS 8 software (Bioinformatics Solutions Inc.) and subjected to de novo sequencing with SwissProt database searching. The tolerance values used were 15 ppm for parent ions and 0.05 Da for fragment ions. See Supplementary Table S1 for information used to identify peptides.
Statistical Analysis
All experiments were carried out three independent times with triplicates of each sample. Means and standard deviations were analyzed using ANOVA followed by Tukey's post hoc test with a P-value of ≤ 0.05 considered significant.
Results
Activity of L. helveticus LH-2 and L. acidophilus La-5 CFSM on Bioluminescent Reporter Strains
Bioluminescent reporter strains S. Typhimurium hilA::lux and ssrB::lux were used for initial screening of the antivirulence effects of CFSM obtained from WPI fermented with L. helveticus LH-2 and L. acidophilus La-5. CFSM from both strains reduced luminescence of the S. Typhimurium hilA::lux while only La-5 could decrease ssrB::lux reporter luminescence; indicating down-regulation of the hilA and ssrB genes (Figures 1A,B). Both uninoculated control WPI had no downregulatory effect on S. Typhimurium hilA::lux light emission with a slight but significant increase in expression of the same gene in WPI glucose based media (Figure 1A). The uninoculated WPI sucrose based medium had no effect on S. Typhimurium ssrB::lux luminescence while WPI glucose based media showed significant down regulation of S. Typhimurium ssrB::lux luminescence (Figure 1B).
Bioluminescent reporter genes are considered a rapid tool for initial monitoring of gene expression. However, bioluminescence may be influenced by several factors, including other components of the medium. Previous observations using luminescent constructs suggest the occurrence of false positives and negatives with respect to virulence gene expression (12, 19, 31, 32). This is why an alternative method was chosen to complement the bioluminescence assay results. RT-qPCR is a highly sensitive and specific method for gene expression analysis.
Effect of L. helveticus LH-2, L. acidophilus La-5 Bioactive Molecules and Mixture of Synthetic Peptides on Virulence Genes in S. Typhimurium DT 104 Wild Type and S. Typhimurium oppA Mutant Strains
The effects of the neutralized and reconstituted CFSM from L. helveticus LH-2 and L. acidophilus La-5 on virulence gene expression in multi-drug resistant S. Typhimurium DT104 and S. Typhimurium oppA mutant were analyzed by a 2-step RT qPCR method after incubation for 3 h (Figure 2). A statistically significant down-regulation of both the hilA and ssrB genes of S. Typhimurium DT 104 was observed after incubation with 10% CFSM from both LH-2 and La-5. La-5 CFSM showed stronger repression of S. Typhimurium DT104 hilA and ssrB genes (−17.8 and −10.49, respectively) than LH-2 CFSM (−2.56 and −1.58, respectively). The expression of hilA and ssrB genes in S. Typhimurium oppA mutant strain was −2.23 and −1.61, respectively, in the presence of La-5 CFSM while in the presence of LH-2 CFSM, expression of both genes was −0.92 and −0.77, respectively (Table 2).
Table 2.
Genes | Target strain | PCR efficiency | Cycle threshold (Ct) values ± standard deviation | |||||
---|---|---|---|---|---|---|---|---|
No treatment | WPI-glucose CFSM | LH-2 CFSM | WPI-sucrose CFSM | La-5 CFSM | Synthetic peptide mixture | |||
16S | S. Typhimurium DT104 | 90.25% | 6.46 ± 0.45 | 5.65 ± 0.33 | 6.61 ± 0.26 | 5.23 ± 0.09 | 5.32 ± 0.08 | 6.27 ± 0.17 |
S. Typhimurium oppA mutant | 7.00 ± 0.42 | 6.19 ± 0.28 | 6.22 ± 0.34 | 6.21 ± 0.42 | 6.08 ± 0.24 | 6.18 ± 1.23 | ||
rpoD | S. Typhimurium DT104 | 93.73% | 22.58 ± 0.22 | 21.46 ± 0.20 | 22.07 ± 0.09 | 19.37 ± 0.21 | 20.75 ± 0.18 | 23.73 ± 0.47 |
S. Typhimurium oppA mutant | 22.21 ± 0.18 | 21.22 ± 0.18 | 21.11 ± 0.27 | 21.23 ± 0.21 | 21.45 ± 0.24 | 22.86 ± 2.78 | ||
gmk | S. Typhimurium DT104 | 101.69% | 29.19 ± 0.82 | 26.95 ± 0.46 | 28.61 ± 0.33 | 25.59 ± 0.58 | 27.96 ± 0.08 | 32.28 ± 0.76 |
S. Typhimurium oppA mutant | 31.12 ± 0.76 | 29.16 ± 0.54 | 29.27 ± 2.23 | 29.63 ± 0.44 | 29.48 ± 0.64 | 32.38 ± 2.76 | ||
hilA | S. Typhimurium DT104 | 96.37% | 23.69 ± 0.36 | 25.31 ± 0.32 | 27.29 ± 0.14 | 20.74 ± 0.31 | 25.41 ± 0.17 | 25.94 ± 0.44 |
S. Typhimurium oppA mutant | 27.07 ± 0.25 | 27.08 ± 0.27 | 27.68 ± 0.48 | 27.74 ± 0.51 | 29.41 ± 0.31 | 30.96 ± 1.64 | ||
ssrB2 | S. Typhimurium DT104 | 97.63% | 26.29 ± 0.34 | 26.21 ± 0.22 | 27.41 ± 0.33 | 22.35 ± 0.06 | 26.67 ± 0.42 | 27.78 ± 0.46 |
S. Typhimurium oppA mutant | 26.14 ± 0.62 | 27.02 ± 0.26 | 27.05 ± 0.53 | 26.64 ± 0.79 | 27.03 ± 0.44 | 28.55 ± 2.41 |
The synthetic peptides mixture could also downregulate the expression of hilA and ssrB genes in S. Typhimurium DT104 (−14.66 and −11.99, respectively). The relative expression of the same genes in the S. Typhimurium oppA mutant strain in the presence of the same peptide mixture was −1.60 and −1.67, respectively (Figure 2).
Genes Associated With Oligopeptide Metabolism in L. helveticus LH-2 and L. acidophilus LA-5
L. helveticus CNRZ 32 and L. acidophilus NCFM have previously sequenced complete genomes with the most thoroughly characterized proteolytic system (15, 33). Whole Genome Sequencing (WGS) and comparative analysis of the proteolytic components of L. helveticus LH-2 and L. acidophilus La-5 with L. helveticus CNRZ 32 and L. acidophilus NCFM, respectively, show some genetic differences in the distribution of proteolytic elements in LH-2 and La-5 (Tables 3, 4). The L. helveticus LH-2 genome codes for prtH3, prtH4, and prtM2 CEP genes (99, 99, and 100% nucleotide identity, respectively) with the absence of prtH, prtH2 and prtM genes (Table 3). The L. acidophilus La-5 genome codes for prtP and prtM CEP genes (99, 100% identity, respectively) (Table 4).
Table 3.
Gene (NCBI accession number) | Identity (%) |
---|---|
CELL ENVELOPE-ASSOCIATED PROTEINASES | |
prtH (AAD50643) | 0 |
prtH2 (DQ826130) | 0 |
prtH3 (HQ602769) | 4,913/4,914 (99%) |
prtH4 (HQ602770) | 4,974/4,977 (99%) |
prtM (DQ826131) | 0 |
prtM2 (DQ826132) | 903/903 (100%) |
OLIGOPEPTIDE TRANSPORT | |
oligopeptide ABC transport protein ATP-binding component OppF2 (AGQ24255.1) | 314/314 (100%) |
oligopeptide ABC transport protein ATP-binding component OppD2 (AGQ24256.1) | 351/352 (99%) |
oligopeptide ABC transport protein ATP-binding component OppF1 (AGQ23787.1) | 328/328 (100%) |
oligopeptide ABC transport protein ATP-binding component OppD1 (AGQ23788.1) | 342/344 (99%) |
oligopeptide ABC transport protein periplasmic component OppA4 (AGQ24260.1) | 496/510 (97%) |
oligopeptide ABC transport protein periplasmic component OppA5 (AGQ24261.1) | 538/540 (99%) |
oligopeptide ABC transport protein ATP-binding component OppB2 (AGQ24258.1) | 309/309 (100%) |
oligopeptide ABC transport protein permease component OppC2 (AGQ24257.1) oligopeptide ABC transport protein permease component OppC1 (AGQ23785.1) |
269/269 (100%) 285/286 (99%) |
PEPTIDASES | |
Oligoendopeptidase pepF (AY365129) | 2,363/2,370 (99%) |
Oligoendopeptidase pepO (AF019410) | 2,690/2,691 (99%) |
Oligoendopeptidase pepO2 (DQ826126) | 1,939/1,947 (99%) |
sialoglycoprotein endopeptidase Ogcp (DQ826107) | 1,050/1,050 (100%) |
General aminopeptidases pepCE (JF811429) | 1,314/1,314 (100%) |
General aminopeptidases pepC (HQ602766) | 1,349/1,350 (99%) |
General aminopeptidases pepN (U08224) | 3,754/3,787 (99%) |
X-prolyl diaminopeptidase pepX (U22900) | 3,204/3,204 (100%) |
Proline iminopeptidases pepI (DQ826125) | 885/885 (100%) |
Proline iminopeptidases pepR (U05214) | 1,259/1,260 (99%) |
Prolidase pepQ (AF012084) | 2,177/2,181 (99%) |
Prolidase pepQ2 (DQ826127) | 1,110/1,110 (100%) |
Dipeptidase pepD (U34257) | 2,244/2,253 (99%) |
Dipeptidase pepD2 (DQ826122) | 1,422/1,422 (100%) |
Dipeptidase pepD3 (DQ826123) | 1,424/1,428 (99%) |
Dipeptidase pepV (AF012085) | 2,402/2,404 (99%) |
Tripeptidase pepT (DQ826128) | 1,242/1,242 (100%) |
Tripeptidase pepT2 (DQ826129) | 1,287/1,287 (100%) |
Glutamyl aminopeptidase pepA (DQ826138) | 1,083/1,083 (100%) |
Methionine aminopeptidase map (DQ826118) | 828/828 (100%) |
Pyrrolidone carboxyl peptidase pcp (DQ826121) | 603/603 (100%) |
SprT-like metallopeptidase sprT (HQ602765) | 470/471 (99%) |
M16 family metallopeptidase hyp prt2 (DQ826112) | 1,257/1,257 (100%) |
Membrane alanine aminopeptidase pepM1 (HQ602768) | 1,515/1,515 (100%) |
Table 4.
Gene (NCBI accession number) | Identity (%) |
---|---|
CELL ENVELOPE-ASSOCIATED PROTEINASES | |
prtP (LBA1512) | 1,626/1,627 (99%) |
prtM (LBA1588) | 300/300 (100%) |
Oligopeptides transport: | |
Oligopeptide binding protein oppA (LBA0197) | 1,626/1,626 (100%) |
Oligopeptide ABC transporter, binding protein oppA1B (LBA0198) | 542/542 (100%) |
Oligopeptide ABC transporter, permease protein oppB1 (LBA0200) | 309/309 (100%) |
Oligopeptide ABC transporter, permease protein oppC1 (LBA0201) | 343/343 (100%) |
Oligopeptide ABC transporter, ATP binding protein oppD1 (LBA0202) | 352/352 (100%) |
Oligopeptide ABC transporter, ATP binding protein oppF1 (LBA0203) | 313/314 (99%) |
Oligopeptide ABC transporter, substrate binding protein oppA3 (LBA1216) | 527/527 (100%) |
Oligopeptide ABC transporter, substrate binding protein oppA2 (LBA1300) | 584/585 (99%) |
Oligopeptide ABC transporter, substrate binding protein oppA2B (LBA1301) | 589/589 (100%) |
Oligopeptide ABC transporter, permease protein oppC2 (LBA1302) | 309/309 (100%) |
Oligopeptide ABC transporter, permease protein oppB2 (LBA1303) | 105/319 (33%) |
Oligopeptide ABC transporter, ATP binding protein oppF2 (LBA1305) | 328/328 (100%) |
Oligopeptide ABC transporter, ATP binding protein oppD2 (LBA1306) | 342/343 (99%) |
Oligopeptide ABC transporter, substrate binding protein oppA6 (LBA1400) | 581/581 (100%) |
Oligopeptide ABC transporter, substrate binding protein oppA9 (LBA1961) | 542/542 (100%) |
PEPTIDASES | |
Dipeptidase (LBA0035) | 466/466 (100%) |
Prolyl aminopeptidase (LBA0092) | 293/293 (100%) |
Metallopeptidase pepO (LBA0165) | 649/650 (99%) |
Pyrrolidone carboxyl peptidase (LBA0186) | 200/200 (100%) |
Dipeptidase pepG (LBA0195) | 437/437 (100%) |
Dipeptidase pepE (LBA0204) | 438/438 (100%) |
Prepilin peptidase (LBA0286) | 228/229 (99%) |
Aminopeptidase C pepC (LBA0343) | 449/449 (100%) |
Endopeptidase (LBA0390) | 348/349 (99%) |
Xaa-pro dipeptidase (LBA0430) | 1,117/1,117 (100%) |
ampM Methionine aminopeptidase (LBA0623) | 274/275 (99%) |
pepC Aminopeptidase (LBA0911) | 437/437 (100%) |
pepD Metallopeptidase (LBA0994) | 467/467 (100%) |
Signal peptidase (LBA1182) | 256/257 (99%) |
pepT Tripeptide aminopeptidase (LBA1190) | 427/427 (100%) |
pepO Metallopeptidase (LBA1275) | 649/650 (99%) |
pepP Xaa-Pro aminopeptidase (LBA1336) | 1,124/1,124 (100%) |
pepQ Metallopeptidase (LBA1343) | 596/596 (100%) |
pepX X-prolyl dipeptidyl aminopeptidase (LBA1373) | 793/793 (100%) |
pepT Tripeptide aminopeptidase (LBA1515) | 427/427 (100%) |
vanY d-alanyl-d-alanine carboxypeptidase (LBA1603) | 1,312/1,312 (100%) |
Prolyl aminopeptidase (LBA1658) | 928/928 (100%) |
pepF Oligoendopeptidase (LBA1763) | 598/598 (100%) |
pepN Membrane alanyl aminopeptidase (LBA1849) | 844/844 (100%) |
Signal peptidase (LBA1909) | 210/210 (100%) |
pepL Leucyl aminopeptidase (LBA1957) | 299/299 (100%) |
Comparative genome analysis of L. helveticus LH-2 for oligopeptide transport elements and peptidases shows the presence of these proteolytic components with high identity (97–100%) (Table 3). The L. acidophilus La-5 genome codes for oligopeptide transport elements and peptidases of L. acidophilus NCFM with high identity (99–100%), except for oppB2 (33% identity) (Table 4).
CEP Activities of L. helveticus LH-2 and L. acidophilus LA-5 in WPI
The CEP activities of intact cells from the medium fermented by L. helveticus LH-2 and L. acidophilus La-5 were measured based on the in vitro hydrolysis of the chromogenic substrate N-succinyl-Ala-Ala-Pro-Phe-p-nitroanilide. The optimal temperature for the proteinase activity of LH-2 strain was 45°C with enzyme activity 3.60 while the maximum CEP activity of La-5 was 0.25 ± 0.01 at 40°C (Table 5).
Table 5.
Temperature (°C) |
Specific proteinase activity | Specific aminopeptidase activity | ||
---|---|---|---|---|
L. helveticus LH-2 | L. acidophilus La-5 | L. helveticus LH-2 | L. acidophilus La-5 | |
35 | 1.66 ± 0.04 | 0.05±nd | 19.74 ± 0.27 | 5.19 ± 0.55 |
40 | 2.12 ± 0.11 | 0.25 ± 0.01 | 22.06 ± 0.60 | 4.08 ± 0.74 |
45 | 3.60±nd | 0.14 ± 0.01 | 7.82 ± 0.91 | 4.43 ± 0.37 |
50 | 3.44 ± 0.03 | 0.21 ± 0.01 | 3.41 ± 0.23 | 2.15 ± 0.72 |
55 | 3.01 ± 0.03 | 0.06 ± 0.01 | 14.78 ± 1.32 | 2.75 ± 0.36 |
Values are the means and SD of independent triplicates. non- detectable (nd) = SD <0·01. Specific enzyme activity is expressed as nmoles ρNa released /mg protein/min.
Intracellular Aminopeptidase Activities of L. helveticus LH-2 and L. acidophilus LA-5 in WPI
For LH-2 intracellular extract, the highest aminopeptidase activity was 22.06 ± 0.60 at 40°C while La-5 optimal activity of aminopeptidase was 5.19 ± 0.55 at 35°C (Table 5). Negligible peptidase activity was detected in the extracellular supernatant using Lys-pNa, indicating that peptidase release from the cells during our experiments was below the detection limit (data not shown).
Peptide Profiling of CSFM of Unfermented WPI and WPI Fermented With L. helveticus LH-2 and L. acidophilus LA-5 Strains
Liquid chromatography–mass spectrometry (LC-MS) analysis of unfermented WPI and WPI fermented with LH-2 and La-5 showed that peptides are almost all fragments of the main milk proteins (109, 75, and 15 milk protein derived peptides, respectively) (Figure 3). Out of these, 56 peptides were unique to the 3-kDa fraction from LH-2 fermented medium while 9 were unique to La-5 fermented medium. CEP cleavage sites are not evenly distributed throughout the protein sequences. Regions of highest proteolytic activity are demonstrated by heat maps of peptides (Figure 4). Thus, the presence of hot spots of cleavage sites are represented by changes in color scale, where red represents more numerous peptides. The undigested WPI shows many plasmin and cathepsin cleavage sites (Figures 5–8). Endogenous milk peptides were mostly not found after fermentation with LH-2 and La-5 strains, except 14 peptides from β-casein and one peptide from αs2-casein (Figure 3). Most peptides found in the supernatant of LH-2 and La-5 fermented media display low-affinity residues for oligopeptide binding proteins (negatively charged amino acids, peptides with glycine, proline and glutamine at position 4, 5, or 6, peptides with proline at second position, VPP and IPP containing peptides and phosphorylated peptides) and higher resistance to peptidase hydrolysis (Figures 5–9).
Identification of bioactive peptide sequences was conducted through a search of the peptide literature databases (Table 6). Out of the 109 peptides in undigested WPI, 39 peptides have previously reported bioactivity (antihypertensive, antimicrobial, antioxidative, immunomodulatory, antithrombotic, opioid and antidiabetic activity). A total of 75 peptides were found in L. helveticus LH-2 CFSM, 19 of these peptides have previously been associated with several categories of bioactivity (ACE-inhibitory, opioid, antimicrobial and antioxidant activities). For L. acidophilus La-5 CFSM, a total of 15 peptides were sequenced, 5 of these peptides have previously been reported with ACE-inhibitory, antioxidant, antimicrobial and anti-caries activities. Some of these peptides have multifunctional properties that can modulate two or more physiological processes (Table 6).
Table 6.
Protein | Peptide | Function | Control | LH-2 | La-5 | References |
---|---|---|---|---|---|---|
Bovine β-CN | RELEELNVPGEIVE | ACE-inhibitory | X | (36) | ||
ELQDKIHPF | ACE-inhibitory | X | (37) | |||
SLVYPFPGPIPN | ACE-inhibitory | X | (38) | |||
LVYPFPGPIPN | ACE-inhibitory | X | (39) | |||
VYPFPGPI | Prolyl endopeptidase-inhibitory | X | (40) | |||
VYPFPGPIPN | Antioxidant, ACE-inhibitory | X | (41) | |||
SLPQNIPPLTQTPV | ACE-inhibitory | X | (42) | |||
SLPQNIPPLTQTPVVVPPFLQPEVM | ACE-inhibitory | X | (36) | |||
LPQNIPPL | Antidiabetic | X | (43) | |||
TQTPVVVPPFLQPE | Antioxidant | X | (44) | |||
GVSKVKEAMAPK | Antioxidant | X | X | X | (45) | |
VKEAMAPK | Antibacterial,!!break Antioxidant, ACE-inhibitory | X | (45–47) | |||
HKEMPFPKYPVEPF | Opioid | X | (48) | |||
EMPFPKYPVEPF | ACE-inhibitory | X | (49) | |||
NLHLPLPLLQ | ACE-inhibitory | X | X | (50) | ||
MHQPHQPLPPT | Antirotaviral Activity | X | (51) | |||
HQPHQPLPPT | Immunomodulatory | X | (52) | |||
SLSQSKVLPVPQ | Antioxidant | X | (53) | |||
SQSKVLPVPQ | ACE-inhibitory | X | X | (54) | ||
RDMPIQAF | ACE-inhibitory | X | (42) | |||
LLYQEPVLGPVRGPFPIIV | ACE-inhibitory, Immunomodulatory, Antithrombin, Antimicrobial | X | (55–57) | |||
LYQEPVLGPVRGPFPIIV | Mitogen | X | (58) | |||
YQEPVLGPVRGPFP | ACE-inhibitory | X | (59) | |||
YQEPVLGPVRGPFPI | Antimicrobial | X | (56, 60) | |||
YQEPVLGPVRGPFPIIV | Immunomodulatory, Antimicrobial | X | (61) | |||
QEPVLGPVRGPFPIIV | ACE-inhibitory, Antioxidant | X | (59, 62) | |||
EPVLGPVRGPFPIIV | ACE-inhibitory | X | (45) | |||
DKIHPFA | ACE-inhibitory | X | (63) | |||
YPFPGPIHNSLPQ | Opioid | X | (64) | |||
LPQNIPPLTQTPV | Antidiabetic, ACE-inhibitory | X | (43, 65) | |||
IPPLTQTPVVVPP | ACE-inhibitory | X | (66) | |||
TPVVVPPFL | ACE-inhibitory | X | (37, 67) | |||
PVVVPPFLQPE | Antimicrobial | X | (60) | |||
DVENLHLPLPL | ACE-inhibitory | X | X | (68) | ||
LHLPLPLLQS | ACE-inhibitory | X | (69) | |||
HLPLPLLQ | Enteric nervous system development | X | (70) | |||
SLSQSKVLPVPQK | Antioxidant | X | (53) | |||
LPVPQKAVPYPQ | Antioxidant | X | (71) | |||
Bovine αs1-CN | EVLNENLLRF | ACE-inhibitory | X | (72) | ||
FVAPFPEVFGK | ACE-inhibitory | X | (73) | |||
VAPFPEVFGKE | ACE-inhibitory | X | (74) | |||
VPQLEIVPNSAEER | Mineral carriers, anti-caries activity | X | (75) | |||
Bovine αs2-CN | LYQGPIVLNPWDQVK | ACE-inhibitory | X | (65) | ||
NAVPITPT | ACE-inhibitory | X | (65) | |||
NAVPITPTL | Antioxidative | X | (76) | |||
Bovine κ-CN | YYQQKPVA | Antibacterial | X | (77) | ||
MAIPPKKNQDKTEIPTIN | Antithrombotic, Antibacterial | X | (78) | |||
TVQVTSTAV | Antibacterial | X | (77, 78) | |||
EIPTINT | Antibacterial | X | (77) | |||
EVIESPPEINTVQVT | ACE-inhibitory, zinc-chelation | X | (79) | |||
Bovine β-LG | IIAEKTKIPA | ACE-inhibitory | X | (80) | ||
LIVTQTMK | Cytotoxic | X | (81) | |||
IDALNENK | Antibacterial | X | (82) | |||
VLVLDTDYK | Antibacterial, DPP-IV inhibitory | X | (60, 83) | |||
AASDISLLDAQSAPLR | Antibacterial | X | (84) | |||
GLDIQKVAGT | ACE-inhibitory, Antibacterial | X | X | (60, 85) | ||
GLDIQKVAGTW | ACE-inhibitory | X | (85) |
Discussion
Several previous studies showed the ability of lactic acid bacteria to down regulate the expression of virulence genes of enteropathogenic bacteria (31, 86, 87). In this study, CFSM collected from WPI fermented by L. helveticus LH-2 and L. acidophilus La-5 reduced the expression of both the hilA and ssrB genes of the S. Typhimurium DT 104 wild strain. L. acidophilus La-5 has the most significant down-regulatory effect on the virulence genes, which indicates that the antivirulence effect is strain dependent and affected by the nature and components of CFSM. WPI fermented by La-5 contains 9 unique peptides not found in LH-2-fermented or unfermented medium.
Delcenserie et al. (32) reported that glucose could up or down-regulate the expression of virulence genes in E. coli O157:H7. In our study, glucose and sucrose may also affect virulence gene expression in S. Typhimurium. A peptidic fraction, isolated from milk fermented with L. helveticus, down-regulated ssrB gene expression of S. Typhimurium in the absence of glucose in the growth medium (10). CFSM from MRS without glucose fermented with some bifidobacteria species showed down-regulation of genes hilA, ssrB2, and sopD (88). These studies suggest that down-regulation of virulence genes could be caused by other non-carbohydrate metabolites produced after fermentation.
Absence of the downregulatory effect of L. helveticus LH-2 and L. acidophilus La-5 CFSM on the Salmonella oppA mutant strain signifies the importance of peptide transport inside S. Typhimurium to inhibit virulence gene expression. Regulation of virulence gene expression requires sensing of a specific signal in the environment such as autoinducers for quorum sensing (QS) and these signals affect the growth, metabolism and virulence of bacteria (89). Exogenous leucine increases the transport of peptides by the Opp system and enhances OppA synthesis (90). Also, activity of Opp increases the intracellular amino acid pool, which in turn activates global regulators such as Lrp or CodY (91). Baek et al. (92) reported that Lrp responds to the nutritional environment and has a repressor function on key virulence regulator genes of S. enterica Serovar Typhimurium by strong interaction with hilA and other SPI-1 and SPI-2 genes, affecting their expression by binding directly to their promoter regions PhilA, PinvF and PssrA. From these studies and our data, it can be concluded that the presence of the S. Typhimurium oppA gene is a key factor in sensing oligopeptides, which can act as a specific signal for down regulation of virulence genes once transported into the cell.
The downregulatory effect of the synthetic peptide mixture demonstrates the antivirulence effect of specific peptides produced by L. helveticus LH-2 and L. acidophilus La-5 CFSM on the S. Typhimurium virulence genes. Also, the absence of this downregulatory effect for the S. Typhimurium oppA mutant strain shows the importance of internalization of such peptides inside S. Typhimurium to exhibit the antivirulence effect.
Presence of more than one CEP paralog is common among L. helveticus strains (93). Also, the presence of prtH3 and prtH4 with the absence of prtH in L. helveticus LH-2 is not unusual as prtH is not broadly distributed within L. helveticus and has no effect on growth rate in milk and cheese whey (94). prtH and prtH2 distribution is also strain dependent (95). The prtH3/prtH4 combination is common in L. helveticus strains (96). These studies agree with our findings for the presence of prtH3 and prtH4 genes and absence of prtH and prtH2 genes in the genome of the LH-2 strain. PrtM is required for activation of PrtH and PrtM2 plays a role in activation of other CEP paralogs in L. helveticus (97). Thus, absence of PrtM in LH-2 is expected as this gene was almost exclusively restricted to strains that also contained prtH (33).
Presence of both PrtP (proteinase precursor) and PrtM (maturase) in L. acidophilus La-5 confirmed that La-5 can digest large proteins extracellularly and produce small peptides. Genay et al. (95) reported that the genetic biodiversity of CEP paralogs between LAB strains could affect growth rate, strain functionality and bioactive peptide production in dairy products. This could cause differences in the antivirulence activities and bioactive peptides between of LH-2 and La-5 after growth in WPI.
Peptide transport systems can be specific for oligopeptides, or di- and tri-peptides (98). L. helveticus LH-2 contains all oligopeptide ABC transport elements, which is not different from previous studies of L. helveticus strains (99). L. acidophilus La-5 shows low identity of oppB2 which is encoded by the opp2-type operon (100). Azcarate-Peril et al. (101) reported that Opp1 and Opp2 might have different specificities, which could explain accumulation of some peptides in La-5 growth media. Doeven et al. (98) also concluded that the lack of some elements of the membrane complex, OppBCDF, leads to presence of some peptides outside the cells due to the specificity of the transport process.
The functionality of these enzymes after genome analysis of L. helveticus LH-2 and L. acidophilus La-5 strains was determined by measuring the proteolytic enzyme activities. The optimal temperature for the proteinase activity of LH-2 (45°C) is not different from other previously reported L. helveticus strains (40–50°C) (102–104). The maximum CEP activity of La-5 (40 and 50°C) also is not significantly different from other L. acidophilus strains (45–50°C) previously reported (105).
L. helveticus LH2 CEP activity in WPI was lower than the CEP activity of other L. helveticus strains previously reported in skim milk (104, 106). The CEP activity of La-5 was slightly lower than the CEP activity of the same strain in skim milk (106) and significantly lower than the CEP activities of other L. acidophilus strains in chemically defined medium (107). The presence of peptides in the growth medium could inhibit the proteinase activity of some LAB (108). Mass spectrometry analysis of non-fermented WPI in this study confirmed the presence of endogenous milk protein derived peptides (β-, αs1-, αs2-, κ-casein, and β-lactoglobulin) after ultrafiltration of milk during the WPI production process. The presence of these endogenous peptides in the growth media could explain the lower CEP activities of LH-2 and La-5 in WPI compared with other related strains in milk-based growth media. The CEP activity levels of lactobacilli depend on the strain, nature and quantity of peptides present in the growth media (96). The regulation of proteinase activity is also strain dependent (107). These factors suggest that CEP activities of LH-2 and La-5 are different in WPI than other milk-based media.
L. helveticus LH-2 aminopeptidase activity in WPI based medium was significantly lower compared with previously studied L. helveticus strains after growth in simplified chemically defined medium (SCDM) supplemented with different nitrogen sources (109). L. acidophilus La-5 had higher aminopeptidase activity compared with L. acidophilus strains mentioned in Pescuma et al. (28) when grown in a chemically defined medium (CDM). The aminopeptidase activities are not influenced by the peptide content of the medium (109), so this difference may be mainly strain dependent (110).
The presence of endogenous peptides in unfermented WPI indicates the activity of endogenous milk proteases which are mainly plasmin, elastase and cathepsin D, B, and G (111). Plasmin has little or no activity toward κ-casein and whey proteins (112), so the presence of endogenous peptides from these proteins in CFSM of L. acidophilus La-5 and L. helveticus LH-2 could be due to the action of other milk proteases such as cathepsin B, D, and G (34, 113). Dallas et al. (114) concluded that minimal proteolysis by native milk enzymes continued to function during incubation in the heat-treated milk when compared with that carried out by the proteases of kefir microorganisms which were mainly L. acidophilus and L. helveticus. This observation could explain the presence of some peptides shared between the unfermented and fermented WPI. Absence of some peptides after WPI fermentation is likely due to either further hydrolysis by LH-2 and La-5 extracellular proteases or their uptake by these microorganisms. The presence of four shared peptides (three from β-casein and one from β-lactoglobulin) in WPI fermented by LH-2 and La-5 strains indicates some similarity in the affinity of the proteinases of these strains for certain cleavage sites.
According to peptide analysis data, most of the identified peptides are casein derived, even though whey was used. The presence of casein derived peptides indicates that these proteins were exposed to proteolytic cleavage during processing (115). The three dimensional structure of caseins is more open and flexible than the globular, rigid, compact structures of whey proteins, which make casein proteins more susceptible to the effect of proteases (116).Whey proteins also are not an important peptide precursor during initial fermentation or endogenous proteolysis (117). This could explain why most peptides in the unfermented and fermented WPI media originate from casein proteins.
Although β-casein is not the most abundant protein in casein, our data showed that about half (47, 72, and 53%) of identified peptides in the WPI and WPI fermented with LH-2 and La-5, respectively, were derived from β-casein. Thus, it can be concluded that the endogenous and microbial proteases of LH-2 and La-5 may preferentially attack β-casein. These findings are consistent with previously studies on bovine casein and kefir (49). The degradation of αs-casein is strain dependent (107). Our results confirm this finding, as La-5 shows different cleavage sites for αs1-casein while αs1-casein derived peptides were not found after fermentation with LH-2. Nielsen et al. (67) reported no peptides from αs1-casein digested with L. helveticus 1198 while Sadat-Mekmene et al. (118) concluded that αs1-casein hydrolysis was enhanced in the presence of both CEPs (prtH, prtH2). The lack of the prtH CEP gene in the L. helveticus LH-2 genome does not explain the absence of αs1-casein derived peptides in LH-2 CFSM, as some of these are present in the control medium. Strain LHC2, which has a similar combination of CEP homologs (PrtH3/PrtH4), does produce peptides from αs1-casein within a 3-h time scale (119). The longer 48-h time scale of the fermentation of WPI by LH-2 may explain the disappearance of αs1-casein peptides, and the lack of larger casein proteins in the WPI medium would preclude the release of additional αs1-casein peptides by LH-2. In contrast, LH-2 can produce αs2-casein derived peptides while La-5 cannot produce them. Pescuma et al. (107) reported that L. acidophilus strain CRL 636 was unable to degrade αs2-casein, which supports the current findings. LH-2 shares some κ-casein cleavage sites with other L. helveticus strains (120) while κ-casein is poorly degraded by La-5 (105). β-lactoglobulin is one of the major milk allergens (121). LH-2 and La-5 strains were able to degrade this protein, which indicates the potential of these strains in the production of hypoallergenic dairy products.
Fira et al. (105) reported that the optimal pH for CEP of L. acidophilus strains tested was 6.5 with a temperature optimum of 45–50°C, which might explain the lower number or diversity of peptides produced by La-5 at a lower pH and temperature (pH 4.5–5.2 at 37°C). The La-5 genome codes for only one CEP when compared with LH-2, which could result in a lower number or diversity of released peptides accumulating in the growth medium. Even though La-5 produces fewer types of peptides, those that are produced have higher antivirulence activity compare to those produced by LH-2, which depends on the nature and structure of the peptides. None of the peptides found in WPI fermented by La-5 are similar to those found in previous studies of the same strain grown in skim milk (52), which emphasizes the significant effect of growth media on the proteolytic activity of LAB.
Accumulation of peptides with predicted antivirulence effect after fermentation despite the active proteolytic and peptidolytic enzymes of L. helveticus LH-2 and L. acidophilus La-5 may be due to the nature and structure of these peptides. Detmers et al. (122) reported that peptides with hydrophobic and aromatic residues have high binding affinity to OppA, while those with proline, glycine, negatively charged amino acids (Aspartate D, glutamate E) and peptides with neutral or positively charged N-terminal residues having Gly, Pro and/or Gln in position 4, 5 and/or 6 significantly lower the affinity of the peptide for OppA protein. Proline at the second position of a nonameric peptide also resulted in a dramatic drop of the OppA binding affinity (122). Phosphorylated peptides and peptides high in proline content are more resistant to hydrolysis by proteolytic enzymes (123, 124). Oligopeptides containing VPP and IPP sequences could release branched chain amino acids (BCAAs) in the presence of specific peptidases. BCAAs could enhance binding of the Branched Chain Amino Acids Responsive Transcriptional Regulator (BCARR) to DNA sequences in the upstream region of the pepV gene, which would repress the expression of some peptidase genes in L. helveticus (125). Most LH-2 and La-5 peptides found in the supernatant display some of these characteristics, which may help explain their accumulation in the fermented WPI medium.
Conclusions
L. helveticus LH-2 and L. acidophilus La-5 produce peptides with antivirulence effect against Salmonella enterica subsp. enterica serovar Typhimurium after growth in whey protein isolate medium. Accumulation of peptides with antivirulence activities may be related to the composition of these peptides and low affinity of these peptides to the oligopeptide-binding protein (OppA) of these strains, thus remaining in the spent medium if they are not transported into the cell. In Salmonella, the antivirulence activity of milk protein-derived peptides is related to the presence of the oppA gene. The undigested and fermented WPI by LH-2 and La-5 strains could be considered as a possible source of natural and functional ingredients, which may be used to increase the biological activity of food products. Further studies are required to explore the antivirulence ability of individual synthetic peptides with the same sequence at different concentrations compared to the antivirulence activity of fermented WPI.
Data Availability Statement
The datasets generated for this study can be found in the the University of Guelph Research Data Repository [https://doi.org/10.5683/SP2/43M6GX].
Author Contributions
EA carried out the experiments, interpreted the results, and wrote the first draft of the manuscript. SN participated in interpretation and presentation of the peptide results. SA-E, AE-L, and ES provided help for interpretation of the results. GL was involved in the design of the study, interpretation of the results, and writing of the manuscript.
Conflict of Interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Footnotes
Funding. This work was supported and funded by Natural Sciences and Engineering Research Council of Canada (NSERC) Industrial Research Chair (IRCSA 505386-15) held by GL and the Cultural Affairs and Mission Sector in Egypt.
Supplementary Material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fnut.2019.00152/full#supplementary-material
References
- 1.Wong MH, Yan M, Chan EW, Biao K, Chen S. Emergence of clinical Salmonella enterica serovar Typhimurium isolates with concurrent resistance to ciprofloxacin, ceftriaxone, and azithromycin. Antimicrob Agents Chemother. (2014) 58:3752–6. 10.1128/AAC.02770-13 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Rasko DA, Sperandio V. Anti-virulence strategies to combat bacteria-mediated disease. Nat Rev Drug Discov. (2010) 9:117–28. 10.1038/nrd3013 [DOI] [PubMed] [Google Scholar]
- 3.Lavigne JP, Blanc-Potard AB. Molecular evolution of Salmonella enterica serovar Typhimurium and pathogenic Escherichia coli: From pathogenesis to therapeutics. Infect Genet Evol. (2008) 8:217–26. 10.1016/j.meegid.2007.11.005 [DOI] [PubMed] [Google Scholar]
- 4.Altier C. Genetic and environmental control of Salmonella invasion. J Microbiol. (2005) 43:85–92. [PubMed] [Google Scholar]
- 5.Lostroh CP, Bajaj V, Lee CA. The cis requirements for transcriptional activation by HilA, a virulence determinant encoded on SPI-1. Mol Microbiol. (2000) 37:300–15. 10.1046/j.1365-2958.2000.01991.x [DOI] [PubMed] [Google Scholar]
- 6.Feng X, Walthers D, Oropeza R, Kenney LJ. The response regulator SsrB activates transcription and binds to a region overlapping OmpR binding sites at Salmonella pathogenicity island 2. Mol Microbiol. (2004) 54:823–35. 10.1111/j.1365-2958.2004.04317.x [DOI] [PubMed] [Google Scholar]
- 7.Nagpal R, Behare P, Rana R, Kumar A, Kumar M, Arora S, et al. Bioactive peptides derived from milk proteins and their health beneficial potentials: an update. Food Funct. (2011) 2:18–27. 10.1039/C0FO00016G [DOI] [PubMed] [Google Scholar]
- 8.Korhonen H. Milk-derived bioactive peptides: from science to applications. J Funct FoodS. (2009) 1:177–87. 10.1016/j.jff.2009.01.007 [DOI] [Google Scholar]
- 9.Medellin-Peña MJ, Griffiths MW. Effect of molecules secreted by Lactobacillus acidophilus strain La-5 on Escherichia coli O157:H7 colonization. Appl Environ Microbiol. (2009) 75:1165–72. 10.1128/AEM.01651-08 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Tellez A, Corredig M, Turner PV, Morales R, Griffiths M. A peptidic fraction from milk fermented with Lactobacillus helveticus protects mice against Salmonella infection. Int Dairy J. (2011) 21:607–14. 10.1016/j.idairyj.2011.03.011 [DOI] [Google Scholar]
- 11.Bayoumi MA, Griffiths MW. In vitro inhibition of expression of virulence genes responsible for colonization and systemic spread of enteric pathogens using Bifidobacterium bifidum secreted molecules. Int J Food Microbiol. (2012) 156:255–63. 10.1016/j.ijfoodmicro.2012.03.034 [DOI] [PubMed] [Google Scholar]
- 12.Zeinhom M, Tellez AM, Delcenserie V, El-Kholy AM, El-Shinawy SH, Griffiths MW. Yogurt containing bioactive molecules produced by Lactobacillus acidophilus La-5 exerts a protective effect against enterohemorrhagic Escherichia coli in mice. J Food Prot. (2012) 75:1796–805. 10.4315/0362-028X.JFP-11-508 [DOI] [PubMed] [Google Scholar]
- 13.López-Fandiño R, Otte J, van Camp J. Physiological, chemical and technological aspects of milk-protein-derived peptides with antihypertensive and ACE-inhibitory activity. Int Dairy J. (2006) 16:1277–93. 10.1016/j.idairyj.2006.06.004 [DOI] [Google Scholar]
- 14.Kenny O, FitzGerald RJ, O'Cuinn G, Beresford T, Jordan K. Growth phase and growth medium effects on the peptidase activities of Lactobacillus helveticus. Int Dairy J. (2003) 13:509–16. 10.1016/S0958-6946(03)00073-6 [DOI] [Google Scholar]
- 15.Altermann E, Russell WM, Azcarate-Peril MA, Barrangou R, Buck BL, McAuliffe O, et al. Complete genome sequence of the probiotic lactic acid bacterium Lactobacillus acidophilus NCFM. Proc Natl Acad Sci USA. (2005) 102:3906–12. 10.1073/pnas.0409188102 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Monnet V. Bacterial oligopeptide-binding proteins. Cell Mol Life Sci. (2003) 60:2100–14. 10.1007/s00018-003-3054-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Goodell EW, Higgins CF. Uptake of cell wall peptides by Salmonella typhimurium and Escherichia coli. J Bacteriol. (1987) 169:3861–5. 10.1128/jb.169.8.3861-3865.1987 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Bayoumi MA, Griffiths MW. Probiotics down-regulate genes in Salmonella enterica serovar typhimurium pathogenicity islands 1 and 2. J Food Prot. (2010) 73:452–60. 10.4315/0362-028X-73.3.452 [DOI] [PubMed] [Google Scholar]
- 19.Guri A, Paligot M, Crvecoeur S, Piedboeuf B, Claes J, Daube G, et al. In vitro screening of mare's milk antimicrobial effect and antiproliverative activity. FEMS Microbiol Lett. (2015) 363:1–7. 10.1093/femsle/fnv234 [DOI] [PubMed] [Google Scholar]
- 20.Asakura H, Ekawa T, Sugimoto N, Momose Y, Kawamoto K, Makino SI, et al. Membrane topology of Salmonella invasion protein SipB confers osmotolerance. Biochem Biophys Res Commun. (2012) 426:654–8. 10.1016/j.bbrc.2012.09.012 [DOI] [PubMed] [Google Scholar]
- 21.Velayudhan J, Karlinsey JE, Frawley ER, Becker LA, Nartea M, Fang FC. Distinct roles of the Salmonella enterica serovar typhimurium CyaY and YggX proteins in the biosynthesis and repair of iron-sulfur clusters. Infect Immun. (2014) 82:1390–401. 10.1128/IAI.01022-13 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Botteldoorn N, Van Coillie E, Grijspeerdt K, Werbrouck H, Haesebrouck F, Donné E, et al. Real-time reverse transcription PCR for the quantification of the mntH expression of Salmonella enterica as a function of growth phase and phagosome-like conditions. J Microbiol Methods. (2006) 66:125–35. 10.1016/j.mimet.2005.11.003 [DOI] [PubMed] [Google Scholar]
- 23.Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. (2001) 29:2002–7. 10.1093/nar/29.9.e45 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Vandesompele J, De Preter K, Pattyn I, Poppe B, Van Roy N, De Paepe A, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. (2002) 3:34–1. 10.1186/gb-2002-3-7-research0034 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Pfaffl M. Quantification strategies in real-time PCR. In: A-Z of Quantitative PCR. IUL Biotechnology Series. La Jolla, CA: International University Line Publishers; (2004). p. 87–112. [Google Scholar]
- 26.Exterkate FA, Alting AC, Bruinenberg PG. Diversity of cell envelope proteinase specificity among strains of Lactococcus lactis and its relationship to charge characteristics of the substrate-binding region. Appl Environ Microbiol. (1993) 59:3640–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. (1976) 72:248–54. 10.1016/0003-2697(76)90527-3 [DOI] [PubMed] [Google Scholar]
- 28.Pescuma M, Hébert EM, Mozzi F, Valdez GFDe. Hydrolysis of whey proteins by Lactobacillus acidophilus, Streptococcus thermophilus and Lactobacillus delbrueckii ssp. bulgaricus grown in a chemically defined medium. J Appl Microbiol. (2007) 103:1738–46. 10.1111/j.1365-2672.2007.03404.x [DOI] [PubMed] [Google Scholar]
- 29.Fernández-Esplá MD, Fox PF, Martín-Hernândez MC. Purification and characterization of a novel serine aminopeptidase from Lactobacillus casei subsp. casei IFPL 731. J Agric Food Chem. (1997) 45:1624–8. 10.1021/jf960889w [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Ma B, Zhang K, Hendrie C, Liang C, Li M, Doherty-Kirby A, et al. Peaks: powerful software for peptide de novo sequencing by tandem mass spectrometry. Rapid Commun Mass Spectrom. (2003) 17:2337–42. 10.1002/rcm.1196 [DOI] [PubMed] [Google Scholar]
- 31.Medellin-Peña MJ, Wang H, Johnson R, Anand S, Griffiths MW. Probiotics affect virulence-related gene expression in Escherichia coli O157:H7. Appl Environ Microbiol. (2007) 73:4259–67. 10.1128/AEM.00159-07 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Delcenserie V, LaPointe G, Charaslertrangsi T, Rabalski A, Griffiths MW. Glucose decreases virulence gene expression of Escherichia coli O157:H7. J Food Prot. (2012) 75:748–52. 10.4315/0362-028X.JFP-11-384 [DOI] [PubMed] [Google Scholar]
- 33.Broadbent JR, Cai H, Larsen RL, Hughes JE, Welker DL, De Carvalho VG, et al. Genetic diversity in proteolytic enzymes and amino acid metabolism among Lactobacillus helveticus strains1. J Dairy Sci. (2011) 94:4313–28. 10.3168/jds.2010-4068 [DOI] [PubMed] [Google Scholar]
- 34.Baum F, Fedorova M, Ebner J, Hoffmann R, Pischetsrieder M. Analysis of the endogenous peptide profile of milk: identification of 248 mainly casein-derived peptides. J Proteome Res. (2013) 12:5447–62. 10.1021/pr4003273 [DOI] [PubMed] [Google Scholar]
- 35.Hurley MJ, Larsen LB, Kelly AL, McSweeney PLH. The milk acid proteinase cathepsin D: a review. Int Dairy J. (2000) 10:673–81. 10.1016/S0958-6946(00)00100-X [DOI] [Google Scholar]
- 36.Gobbetti M, Ferranti P, Smacchi E, Goffredi F, Addeo F. Production of angiotensin-I-converting-enzyme-inhibitory peptides in fermented milks started by Lactobacillus delbrueckii subsp. bulgaricus SS1 and Lactococcus lactis subsp. cremoris FT4. Appl Environ Microbiol. (2000) 66:3898–904. 10.1128/AEM.66.9.3898-3904.2000 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Robert MC, Razaname A, Mutter M, Juillerat MA. Identification of angiotensin-I-converting enzyme inhibitory peptides derived from sodium caseinate hydrolysates produced by Lactobacillus helveticus NCC 2765. J Agric Food Chem. (2004) 52:6923–31. 10.1021/jf049510t [DOI] [PubMed] [Google Scholar]
- 38.Saito T, Nakamura T, Kitazawa H, Kawai Y, Itoh T. Isolation and structural analysis of antihypertensive peptides that exist naturally in gouda cheese. J Dairy Sci. (2000) 83:1434–40. 10.3168/jds.S0022-0302(00)75013-2 [DOI] [PubMed] [Google Scholar]
- 39.Miguel M, Gómez-Ruiz JÁ, Recio I, Aleixandre A. Changes in arterial blood pressure after single oral administration of milk-casein-derived peptides in spontaneously hypertensive rats. Mol Nutr Food Res. (2010) 54:1422–7. 10.1002/mnfr.200900448 [DOI] [PubMed] [Google Scholar]
- 40.Asano M, Nio N, Ariyoshi Y. Inhibition of prolyl endopeptidase by synthetic beta-casein peptides and their derivatives with a C-terminal prolinol or prolinal. Biosci Biotechnol Biochem. (1992) 56:976–7. 10.1271/bbb.56.976 [DOI] [PubMed] [Google Scholar]
- 41.Eisele T, Stressler T, Kranz B, Fischer L. Bioactive peptides generated in an enzyme membrane reactor using Bacillus lentus alkaline peptidase. Eur Food Res Technol. (2013) 236:483–90. 10.1007/s00217-012-1894-5 [DOI] [Google Scholar]
- 42.Yamamoto N, Akino A, Takano T. Antihypertensive effect of the peptides derived from casein by an extracellular proteinase from Lactobacillus helveticus CP790. J. Dairy Sci. (1994) 77:917–22. 10.3168/jds.S0022-0302(94)77026-0 [DOI] [PubMed] [Google Scholar]
- 43.Uenishi H, Kabuki T, Seto Y, Serizawa A, Nakajima H. Isolation and identification of casein-derived dipeptidyl-peptidase 4 (DPP-4)-inhibitory peptide LPQNIPPL from gouda-type cheese and its effect on plasma glucose in rats. Int Dairy J. (2012) 22:24–30. 10.1016/j.idairyj.2011.08.002 [DOI] [Google Scholar]
- 44.Bamdad F, Shin SH, Suh JW, Nimalaratne C, Sunwoo H. Anti-inflammatory and antioxidant properties of casein hydrolysate produced using high hydrostatic pressure combined with proteolytic enzymes. Molecules. (2017) 22:609. 10.3390/molecules22040609 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Ha GE, Chang OK, Han GS, Ham JS, Park BY, Jeong SG. Comparison of antioxidant activities of hydrolysates of domestic and imported skim milk powders treated with papain. Korean J Food Sci Anim Resour. (2015) 35:360–9. 10.5851/kosfa.2015.35.3.360 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Korhonen H, Pihlanto A. Technological options for the production of health-promoting proteins and peptides derived from milk and colostrum. Curr Pharm Des. (2007) 13:829–43. 10.2174/138161207780363112 [DOI] [PubMed] [Google Scholar]
- 47.Sedaghati M, Ezzatpanah H, Boojar MMA, Ebrahimi MT, Kobarfard F. Isolation and identification of some antibacterial peptides in the plasmin-digest of β-casein. LWT Food Sci. Technol. (2016) 68:217–25. 10.1016/j.lwt.2015.12.019 [DOI] [Google Scholar]
- 48.Plaisancié P, Claustre J, Estienne M, Henry G, Boutrou R, Paquet A, et al. A novel bioactive peptide from yoghurts modulates expression of the gel-forming MUC2 mucin as well as population of goblet cells and Paneth cells along the small intestine. J Nutr Biochem. (2013) 24:213–21. 10.1016/j.jnutbio.2012.05.004 [DOI] [PubMed] [Google Scholar]
- 49.Liu Y, Pischetsrieder M. Identification and relative quantification of bioactive peptides sequentially released during simulated gastrointestinal digestion of commercial kefir. J Agric Food Chem. (2017) 65:1865–73. 10.1021/acs.jafc.6b05385 [DOI] [PubMed] [Google Scholar]
- 50.Miguel M, Recio I, Ramos M, Delgado M, Aleixandre M. Antihypertensive effect of peptides obtained from Enterococcus faecalis-fermented milk in rats. J. Dairy Sci. (2006) 89:3352–9. 10.3168/jds.S0022-0302(06)72372-4 [DOI] [PubMed] [Google Scholar]
- 51.Chenoll E, Casinos B, Bataller E, Buesa J, Ramón D, Genovés S, et al. Identification of a peptide produced by Bifidobacterium longum CECT 7210 with antirotaviral activity. Front Microbiol. (2016) 7:655. 10.3389/fmicb.2016.00655 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Tellez A, Corredig M, Brovko LY, Griffiths MW. Characterization of immune-active peptides obtained from milk fermented by Lactobacillus helveticus. J Dairy Res. (2010) 77:129. 10.1017/S002202990999046X [DOI] [PubMed] [Google Scholar]
- 53.Hernandez-Ledesma B, Amigo L, Ramos M, Recio I. Angiotensin converting enzyme inhibitory activity in commercial fermented products. formation of peptides under simulated gastrointestinal digestion. J Agric Food Chem. (2004) 52:1504–10. 10.1021/jf034997b [DOI] [PubMed] [Google Scholar]
- 54.Hayes M, Stanton C, Slattery H, O'Sullivan O, Hill C, Fitzgerald GF, et al. Casein fermentate of Lactobacillus animalis DPC6134 contains a range of novel propeptide angiotensin-converting enzyme inhibitors. Appl Environ Microbiol. (2007) 73:4658–67. 10.1128/AEM.00096-07 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Bonomi F, Brandt R, Favalli S, Ferranti P, Fierro O, Frøkiær H, et al. Structural determinants of the immunomodulatory properties of the C-terminal region of bovine β-casein. Int Dairy J. (2011) 21:770–6. 10.1016/j.idairyj.2011.04.012 [DOI] [Google Scholar]
- 56.Birkemo GA, O'Sullivan O, Ross RP, Hill C. Antimicrobial activity of two peptides casecidin 15 and 17, found naturally in bovine colostrum. J Appl Microbiol. (2009) 106:233–40. 10.1111/j.1365-2672.2008.03996.x [DOI] [PubMed] [Google Scholar]
- 57.Rojas-Ronquillo R, Cruz-Guerrero A, Flores-Nájera A, Rodríguez-Serrano G, Gómez-Ruiz L, Reyes-Grajeda JP, et al. Antithrombotic and angiotensin-converting enzyme inhibitory properties of peptides released from bovine casein by Lactobacillus casei Shirota. Int Dairy J. (2012) 26:147–54. 10.1016/j.idairyj.2012.05.002 [DOI] [Google Scholar]
- 58.Coste M, Rochet V, Léonil J, Mollé D, Bouhallab S, Tomé D. Identification of C-terminal peptides of bovine β-casein that enhance proliferation of rat lymphocytes. Immunol Lett. (1992) 33:41–6. 10.1016/0165-2478(92)90091-2 [DOI] [PubMed] [Google Scholar]
- 59.Ha GE, Chang OK, Jo SM, Han GS, Park BY, Ham JS, et al. Identification of antihypertensive peptides derived from low molecular weight casein hydrolysates generated during fermentation by Bifidobacterium longum KACC 91563. Korean J Food Sci Anim Resour. (2015) 35:738–47. 10.5851/kosfa.2015.35.6.738 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Almaas H, Eriksen E, Sekse C, Comi I, Flengsrud R, Holm H, et al. Antibacterial peptides derived from caprine whey proteins, by digestion with human gastrointestinal juice. Br J Nutr. (2011) 106:896–905. 10.1017/S0007114511001085 [DOI] [PubMed] [Google Scholar]
- 61.Silva SV, Malcata FX. Caseins as source of bioactive peptides. Int Dairy J. (2005) 15:1–15. 10.1016/j.idairyj.2004.04.009 [DOI] [Google Scholar]
- 62.Sabeena Farvin KH, Baron CP, Nielsen NS, Otte J, Jacobsen C. Antioxidant activity of yoghurt peptides: Part 2 - Characterisation of peptide fractions. Food Chem. (2010) 123:1090–7. 10.1016/j.foodchem.2010.05.029 [DOI] [Google Scholar]
- 63.Quirós A, Hernández-Ledesma B, Ramos M, Amigo L, Recio I. Angiotensin-converting enzyme inhibitory activity of peptides derived from caprine kefir. J Dairy Sci. (2005) 88:3480–7. 10.3168/jds.S0022-0302(05)73032-0 [DOI] [PubMed] [Google Scholar]
- 64.Rokka T, Syväoja EL, Tuominen J, Korhonen H. Release of bioactive peptides by enzymatic proteolysis of Lactobacillus GG fermented UHT milk. Milchwissenschaft. (1997) 52:675–7. [Google Scholar]
- 65.Nongonierma AB, Mazzocchi C, Paolella S, FitzGerald RJ. Release of dipeptidyl peptidase IV (DPP-IV) inhibitory peptides from milk protein isolate (MPI) during enzymatic hydrolysis. Food Res Int. (2017) 94:79–89. 10.1016/j.foodres.2017.02.004 [DOI] [PubMed] [Google Scholar]
- 66.Nakamura Y, Yamamoto N, Sakai K, Okubo A, Yamazaki S, Takano T. Purification and characterization of angiotensin I-converting enzyme inhibitors from sour milk. J Dairy Sci. (1995) 78:777–83. 10.3168/jds.S0022-0302(95)76689-9 [DOI] [PubMed] [Google Scholar]
- 67.Nielsen MS, Martinussen T, Flambard B, Sørensen KI, Otte J. Peptide profiles and angiotensin-I-converting enzyme inhibitory activity of fermented milk products: Effect of bacterial strain, fermentation pH, and storage time. Int Dairy J. (2009) 19:155–65. 10.1016/j.idairyj.2008.10.003 [DOI] [Google Scholar]
- 68.Qureshi TM, Vegarud GE, Abrahamsen RK, Skeie S. Characterization of the Norwegian autochthonous cheese Gamalost and its angiotensin I-converting enzyme (ACE) inhibitory activity during ripening. Dairy Sci Technol. (2012) 92:613–25. 10.1007/s13594-012-0078-1 [DOI] [PubMed] [Google Scholar]
- 69.García-Tejedor A, Sánchez-Rivera L, Recio I, Salom JB, Manzanares P. Dairy Debaryomyces hansenii strains produce the antihypertensive casein-derived peptides LHLPLP and HLPLP. LWT Food Sci Technol. (2015) 61:550–6. 10.1016/j.lwt.2014.12.019 [DOI] [Google Scholar]
- 70.Cossais F, Clawin-Rädecker I, Lorenzen PC, Klempt M. Short communication: Tryptic β-casein hydrolysate modulates enteric nervous system development in primary culture. J Dairy Sci. (2017) 100:3396–403. 10.3168/jds.2016-11440 [DOI] [PubMed] [Google Scholar]
- 71.Rival SG, Boeriu CG, Wichers HJ. Caseins and casein hydrolysates. 2. Antioxidative properties and relevance to lipoxygenase inhibition. J Agric Food Chem. (2001) 49:295–302. 10.1021/jf0003911 [DOI] [PubMed] [Google Scholar]
- 72.Torres-Llanez MJ, González-Córdova F, Hernandez-Mendoza A, Garcia HS, Vallejo-Cordoba B. Angiotensin-converting enzyme inhibitory activity in Mexican Fresco cheese. J. Dairy Sci. (2011) 94:3794–800. 10.3168/jds.2011-4237 [DOI] [PubMed] [Google Scholar]
- 73.Ong L, Shah NP. Release and identification of angiotensin-converting enzyme-inhibitory peptides as influenced by ripening temperatures and probiotic adjuncts in Cheddar cheeses. LWT Food Sci Technol. (2008) 41:1555–66. 10.1016/j.lwt.2007.11.026 [DOI] [Google Scholar]
- 74.del Mar Contreras M, Carrón R, Montero MJ, Ramos M, Recio I. Novel casein-derived peptides with antihypertensive activity. Int Dairy J. (2009) 19:566–73. 10.1016/j.idairyj.2009.05.004 [DOI] [Google Scholar]
- 75.Smacchi E, Gobbetti M. Bioactive peptides in dairy products: synthesis and interaction proteolytic enzymes. Food Microbiol. (2000) 17:129–41. 10.1006/fmic.1999.0302 [DOI] [Google Scholar]
- 76.Shanmugam VP, Kapila S, Sonfack TK, Kapila R. Antioxidative peptide derived from enzymatic digestion of buffalo casein. Int Dairy J. (2015) 42:1–5. 10.1016/j.idairyj.2014.11.001 [DOI] [Google Scholar]
- 77.López-Expósito I, Minervini F, Amigo L, And Recio I. Identification of Antibacterial Peptides from Bovine κ-Casein. J Food Prot. (2006) 69:2992–7. 10.4315/0362-028X-69.12.2992 [DOI] [PubMed] [Google Scholar]
- 78.Rizzello CG, Losito I, Gobbetti M, Carbonara T, De Bari MD, Zambonin PG. Antibacterial activities of peptides from the water-soluble extracts of Italian cheese varieties. J Dairy Sci. (2005) 88:2348–60. 10.3168/jds.S0022-0302(05)72913-1 [DOI] [PubMed] [Google Scholar]
- 79.Daliri EBM, Lee BH, Park BJ, Kim SH, Oh DH. Antihypertensive peptides from whey proteins fermented by lactic acid bacteria. Food Sci Biotechnol. (2018) 27:1781–9. 10.1007/s10068-018-0423-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 80.Power O, Fernández A, Norris R, Riera FA, FitzGerald RJ. Selective enrichment of bioactive properties during ultrafiltration of a tryptic digest of β-lactoglobulin. J Funct Foods. (2014) 9:38–47. 10.1016/j.jff.2014.04.002 [DOI] [Google Scholar]
- 81.Jacquot A, Gauthier SF, Drouin R, Boutin Y. Proliferative effects of synthetic peptides from β-lactoglobulin and α-lactalbumin on murine splenocytes. Int Dairy J. (2010) 20:514–21. 10.1016/j.idairyj.2010.02.013 [DOI] [Google Scholar]
- 82.Sedaghati M, Ezzatpanah H, Boojar MMA, Ebrahimi MT, Aminafshar M. Plasmin-digest of β-lactoglobulin with antibacterial properties. Food Agric. Immunol. (2015) 26:218–30. 10.1080/09540105.2014.893998 [DOI] [Google Scholar]
- 83.Silveira ST, Martínez-Maqueda D, Recio I, Hernández-Ledesma B. Dipeptidyl peptidase-IV inhibitory peptides generated by tryptic hydrolysis of a whey protein concentrate rich in β-lactoglobulin. Food Chem. (2013) 141:1072–7. 10.1016/j.foodchem.2013.03.056 [DOI] [PubMed] [Google Scholar]
- 84.López Expósito I, Recio I. Antibacterial activity of peptides and folding variants from milk proteins. Int Dairy J. (2006) 16:1294–305. 10.1016/j.idairyj.2006.06.002 [DOI] [Google Scholar]
- 85.Pihlanto-Leppälä A, Rokka T, Korhonen H. Angiotensin I converting enzyme inhibitory peptides derived from bovine milk proteins. Int Dairy J. (1998) 8:325–31. 10.1016/S0958-6946(98)00048-X [DOI] [Google Scholar]
- 86.Brovko LY, Vandenende C, Chu B, Ng K-Y, Brooks A, Griffiths MW. In vivo assessment of effect of fermented milk diet on course of infection in mice with bioluminescent Salmonella. J Food Prot. (2003) 66:2160–3. 10.4315/0362-028X-66.11.2160 [DOI] [PubMed] [Google Scholar]
- 87.Vinderola G, Matar C, Perdigón G. Milk fermented by Lactobacillus helveticus R389 and its non-bacterial fraction confer enhanced protection against Salmonella enteritidis serovar Typhimurium infection in mice. Immunobiology. (2007) 212:107–18. 10.1016/j.imbio.2006.09.003 [DOI] [PubMed] [Google Scholar]
- 88.Bondue P, Crèvecoeur S, Brose F, Daube G, Seghaye MC, Griffiths MW, et al. Cell-free spent media obtained from Bifidobacterium bifidum and Bifidobacterium crudilactis grown in media supplemented with 3'-sialyllactose modulate virulence gene expression in Escherichia coli O157: H7 and Salmonella Typhimurium. Front Microbiol. (2016) 7:1460. 10.3389/fmicb.2016.01460 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 89.Rumbaugh KP. Convergence of hormones and autoinducers at the host/pathogen interface. Anal Bioanal Chem. (2007) 387:425–35. 10.1007/s00216-006-0694-9 [DOI] [PubMed] [Google Scholar]
- 90.Andrews JC, Blevins TC, Short SA. Regulation of peptide transport in Escherichia coli: Induction of the trp-linked operon encoding the oligopeptide permease. J Bacteriol. (1986) 165:428–33. 10.1128/jb.165.2.428-433.1986 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 91.Claverys JP, Grossiord B, Alloing G. Is the Ami-Alia/B oligopeptide permease of Streptococcus pneumoniae involved in sensing environmental conditions? Res Microbiol. (2000) 151:457–63. 10.1016/S0923-2508(00)00169-8 [DOI] [PubMed] [Google Scholar]
- 92.Baek CH, Wang S, Roland KL, Curtiss R. Leucine-responsive regulatory protein (Lrp) acts as a virulence repressor in Salmonella enterica serovar typhimurium. J Bacteriol. (2009) 191:1278–92. 10.1128/JB.01142-08 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 93.Savijoki K, Ingmer H, Varmanen P. Proteolytic systems of lactic acid bacteria. Appl Microbiol Biotechnol. (2006) 71:394–406. 10.1007/s00253-006-0427-1 [DOI] [PubMed] [Google Scholar]
- 94.Pederson JA, Mileski GJ, Weimer BC, Steele JL. Genetic characterization of a cell envelope-associated proteinase from Lactobacillus helveticus CNRZ32. J Bacteriol. (1999) 181:4592–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 95.Genay M, Sadat L, Gagnaire V, Lortal S. PrtH2, Not prtH, Is the ubiquitous cell wall proteinase gene in Lactobacillus helveticus. Appl Environ Microbiol. (2009) 75:3238–49. 10.1128/AEM.02395-08 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 96.Sadat-Mekmene L, Genay M, Atlan D, Lortal S, Gagnaire V. Original features of cell-envelope proteinases of Lactobacillus helveticus. A review. Int J Food Microbiol. (2011) 146:1–13. 10.1016/j.ijfoodmicro.2011.01.039 [DOI] [PubMed] [Google Scholar]
- 97.Zhao W, Chen Y, Sun Z, Wang J, Zhou Z, Sun T, et al. Complete genome sequence of Lactobacillus helveticus H10. J Bacteriol. (2011) 193:2666–7. 10.1128/JB.00166-11 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 98.Doeven MK, Kok J, Poolman B. Specificity and selectivity determinants of peptide transport in Lactococcus lactis and other microorganisms. Mol Microbiol. (2005) 57:640–9. 10.1111/j.1365-2958.2005.04698.x [DOI] [PubMed] [Google Scholar]
- 99.Liu M, Bayjanov JR, Renckens B, Nauta A, Siezen RJ. The proteolytic system of lactic acid bacteria revisited : a genomic comparison. BMC Genomics. (2010) 11:36. 10.1186/1471-2164-11-36 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 100.Azcarate-Peril MA, Mcauliffe O, Altermann E, Lick S, Russell WM, Klaenhammer TR. Microarray analysis of a two-component regulatory system involved in acid resistance and proteolytic activity in Lactobacillus acidophilus. Society. (2005) 71:5794–804. 10.1128/AEM.71.10.5794-5804.2005 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 101.Azcarate-Peril Ma, Tallon R, Klaenhammer TR. Temporal gene expression and probiotic attributes of Lactobacillus acidophilus during growth in milk. J Dairy Sci. (2009) 92:870–86. 10.3168/jds.2008-1457 [DOI] [PubMed] [Google Scholar]
- 102.Yamamoto N, Akino A, Takano T. Purification and specificity of a cell-wall-associated proteinase from Lactobacillus helveticus CP790. J Biochem. (1993) 114:740–5. 10.1093/oxfordjournals.jbchem.a124247 [DOI] [PubMed] [Google Scholar]
- 103.Martín-Hernández MC, Alting AC, Exterkate FA. Purification and characterization of the mature, membrane-associated cell-envelope proteinase of Lactobacillus helveticus L89. Appl Microbiol Biotechnol. (1994) 40:828–34. 10.1007/BF00173983 [DOI] [Google Scholar]
- 104.Miyamoto M, Ueno HM, Watanabe M, Tatsuma Y, Seto Y, Miyamoto T, et al. Distinctive proteolytic activity of cell envelope proteinase of Lactobacillus helveticus isolated from airag, a traditional Mongolian fermented mare's milk. Int J Food Microbiol. (2015) 197:65–71. 10.1016/j.ijfoodmicro.2014.12.012 [DOI] [PubMed] [Google Scholar]
- 105.Fira D, Kojic M, Banina A, Spasojevic I, Strahinic I, Topisirovic L. Characterization of cell envelope-associated proteinases of thermophilic lactobacilli. J Appl Microbiol. (2001) 90:123–30. 10.1046/j.1365-2672.2001.01226.x [DOI] [PubMed] [Google Scholar]
- 106.Beganović J, Kos B, Leboš Pavunc A, Uroić K, DŽidara P, Šušković J. Proteolytic activity of probiotic strain Lactobacillus helveticus M92. Anaerobe. (2013) 20:58–64. 10.1016/j.anaerobe.2013.02.004 [DOI] [PubMed] [Google Scholar]
- 107.Pescuma M, Espeche Turbay MB, Mozzi F, De Valdez GF, De Giori GS, Hebert EM. Diversity in proteinase specificity of thermophilic lactobacilli as revealed by hydrolysis of dairy and vegetable proteins. Appl Microbiol Biotechnol. (2013) 97:7831–44. 10.1007/s00253-013-5037-0 [DOI] [PubMed] [Google Scholar]
- 108.Hebert EM, Mamone G, Picariello G, Raya RR, Savoy G, Ferranti P, et al. Characterization of the pattern of alphas1- and beta-casein breakdown and release of a bioactive peptide by a cell envelope proteinase from Lactobacillus delbrueckii subsp. lactis CRL 581. Appl Environ Microbiol. (2008) 74:3682–9. 10.1128/AEM.00247-08 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 109.Hebert EM, Raya RR, DeGiori GS. Nutritional requirements and nitrogen-dependent regulation of proteinase activity of Lactobacillus helveticus CRL 1062. Appl Environ Microbiol. (2000) 66:5316–21. 10.1128/AEM.66.12.5316-5321.2000 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 110.Meijer W, Marugg JD, Hugenholtz J. Regulation of proteolytic enzyme activity in lactococcus lactis. Appl Environ Microbiol. (1996) 62:156–61. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 111.Dallas DC, Weinborn V, de Moura Bell JMLN, Wang M, Parker EA, Guerrero A, et al. Comprehensive peptidomic and glycomic evaluation reveals that sweet whey permeate from colostrum is a source of milk protein-derived peptides and oligosaccharides. Food Res Int. (2014) 63:203–9. 10.1016/j.foodres.2014.03.021 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 112.Yamamoto N, Ono H, Maeno M, Ueda Y, Takano T, Momose H. Classification of Lactobacillus helveticus strains by immunological differences in extracellular proteinases. Biosci Biotechnol Biochem. (1998) 62:1228–30. 10.1271/bbb.62.1228 [DOI] [PubMed] [Google Scholar]
- 113.Considine T, Healy Á, Kelly AL, McSweeney PLH. Hydrolysis of bovine caseins by cathepsin B, a cysteine proteinase indigenous to milk. Int Dairy J. (2004) 14:117–24. 10.1016/S0958-6946(03)00171-7 [DOI] [Google Scholar]
- 114.Dallas DC, Citerne F, Tian T, Silva VLM, Kalanetra KM, Frese SA, et al. Peptidomic analysis reveals proteolytic activity of kefir microorganisms on bovine milk proteins. Food Chem. (2016) 197:273–84. 10.1016/j.foodchem.2015.10.116 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 115.Dallas DC, Guerrero A, Parker EA, Garay LA, Bhandari A, Lebrilla CB, et al. Peptidomic profile of milk of Holstein cows at peak lactation. J Agric Food Chem. (2014) 62:58–65. 10.1021/jf4040964 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 116.Dallas DC, Guerrero A, Khaldi N, Castillo PA, Martin WF, Smilowitz JT, et al. Extensive in vivo human milk peptidomics reveals specific proteolysis yielding protective antimicrobial peptides. J Proteome Res. (2013) 12:2295–304. 10.1021/pr400212z [DOI] [PMC free article] [PubMed] [Google Scholar]
- 117.Ebner J, Aşçi Arslan A, Fedorova M, Hoffmann R, Küçükçetin A, Pischetsrieder M. Peptide profiling of bovine kefir reveals 236 unique peptides released from caseins during its production by starter culture or kefir grains. J Proteomics. (2015) 117:41–57. 10.1016/j.jprot.2015.01.005 [DOI] [PubMed] [Google Scholar]
- 118.Sadat-Mekmene L, Jardin J, Corre C, Mollé D, Richoux R, Delage MM, et al. Simultaneous presence of PrtH and PrtH2 proteinases in Lactobacillus helveticus strains improves breakdown of the pure αs1-casein. Appl Environ Microbiol. (2011) 77:179–86. 10.1128/AEM.01466-10 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 119.Jensen MP, Vogensen FK, Ardö Y. Variation in caseinolytic properties of six cheese related Lactobacillus helveticus strains. Int Dairy J. (2009) 19:661–8. 10.1016/j.idairyj.2009.04.001 [DOI] [Google Scholar]
- 120.Scolari G, Vescovo M, Zacconi C, Vescovi F. Extraction and partial characterization of proteolytic activities from the cell surface of Lactobacillus helveticus Zuc2. J Dairy Sci. (2006) 89:3800–9. 10.3168/jds.S0022-0302(06)72421-3 [DOI] [PubMed] [Google Scholar]
- 121.Picariello G, Mamone G, Addeo F, Ferranti P. The frontiers of mass spectrometry-based techniques in food allergenomics. J Chromatogr A. (2011) 1218:7386–98. 10.1016/j.chroma.2011.06.033 [DOI] [PubMed] [Google Scholar]
- 122.Detmers FJ, Lanfermeijer FC, Abele R, Jack RW, Tampe R, Konings WN, et al. Combinatorial peptide libraries reveal the ligand-binding mechanism of the oligopeptide receptor OppA of Lactococcus lactis. Proc Natl Acad Sci USA. (2000) 97:12487–92. 10.1073/pnas.220308797 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 123.Deutsch SM, Molle D, Gagnaire V, Piot M, Atlan D, Lortal S. Hydrolysis of sequenced β-casein peptides provides new insight into peptidase activity from thermophilic lactic acid bacteria and highlights intrinsic resistance of phosphopeptides. Appl Environ Microbiol. (2000) 66:5360–7. 10.1128/AEM.66.12.5360-5367.2000 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 124.Algaron F, Miranda G, Le Bars D, Monnet V. Milk fermentation by Lactococcus lactis with modified proteolytic systems to accumulate potentially bio-active peptides. Lait. (2004) 84:115–23. 10.1051/lait:2003034 [DOI] [Google Scholar]
- 125.Wakai T, Yamamoto N. A novel branched chain amino acids responsive transcriptional regulator, BCARR, negatively acts on the proteolytic system in Lactobacillus helveticus. PLoS ONE. (2013) 8:e75976. 10.1371/journal.pone.0075976 [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The datasets generated for this study can be found in the the University of Guelph Research Data Repository [https://doi.org/10.5683/SP2/43M6GX].